Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Natus Medical Inc    BABY   US6390501038

NATUS MEDICAL INC (BABY)

5
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

04/17/2012 | 07:05am US/Eastern

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
InvestorRelations@Natus.com
Vice President and Chief Financial Officer


© Business Wire 2012
React to this article
Latest news on NATUS MEDICAL INC
11/05 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
10/23 NATUS MEDICAL : Hears Higher Margins Calling
10/22 NATUS MEDICAL : tops Street 3Q forecasts
10/22 NATUS MEDICAL : Results of Operations and Financial Condition, Financial Stateme..
10/22 NATUS MEDICAL : Announces Record Third Quarter and Year-to-Date 2014 Financial R..
10/16 NATUS MEDICAL : Announces First of Kind Vista Ultrasound System
10/08 NATUS MEDICAL : to Hold 2014 Third Quarter Financial Results Conference Call on ..
09/19 NATUS MEDICAL : New Opaque Tritan Copolyester from Eastman Selected for New Natu..
08/21 NATUS MEDICAL : Patent Issued for Wireless Physiological Monitoring
08/19 NATUS MEDICAL : Assigned Patent
Advertisement
Chart
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF